Editorial Contributor
Richard Moore, Scientific Director, Eucomed
Richard Moore has worked for nearly eight years as scientific director of Eucomed. Prior to joining Eucomed, he worked for six years at the European Committee for Standardization (CEN), where he was responsible for the healthcare department. A forensic biologist by training, he is a European Professional Biologist (EurProBiol) and a Fellow of the Institute of Nanotechnology (FIoN).
Richard Moore of Eucomed argues for the risk-based approach to regulation used in the medical device field.
The application of new and convergent technologies on the nanoscale is already making devices more patient-friendly.
